Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy-Reference-Cited by-同舟云学术

Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy

Published:2006 Issue:5 Volume:106 Page:1000-1006
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hennessy Bryan T.,Gonzalez-Angulo Ana Maria,Hortobagyi Gabriel N.,Cristofanilli Massimo,Kau Shu Wan,Broglio Kristine,Fornage Bruno,Singletary S. Eva,Sahin Aysegul,Buzdar Aman U.,Valero Vicente

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group.

2. Results of cancer and leukemia group B protocol 8935

3. Principles of induction chemotherapy for non-small cell lung cancer

4. Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data;The Breast;2024-10

2. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer;Breast Cancer Research and Treatment;2023-12-28

3. Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting;Cancers;2023-04-25

4. Tailoring Treatment for Patients with Inflammatory Breast Cancer;Current Treatment Options in Oncology;2023-04-12

5. Neoplasms of the Breast;Holland‐Frei Cancer Medicine;2022-10-21